The global burden of Alzheimer’s disease and related dementias: New public health intervention targets driven by the long-term impact of COVID-19 and sex and age differences

INTRODUCTION: This study focuses on the impact and future trends of COVID-19 on the burden of Alzheimer's disease and related dementias (ADRD), analyzing multidimensional differences in the burden of disease for ADRD in 204 countries between 1990 and 2021. METHODS: Using Global Burden of Disease (GBD) data (1990-2021), we analyzed Alzheimer's disease and related dementias (ADRD) prevalence and burden across 204 countries, stratified by sex and age. Joinpoint regression identified temporal inflection points in incidence, mortality, disability-adjusted life years (DALYs), and years of life lost (YLL), while age-standardized rates and estimated annual percentage changes assessed global burden trends. We further evaluated ADRD-associated risk factors, quantified COVID-19's impact through excess burden attribution models, and projected incidence trajectories to 2050 via Bayesian Age-Period-Cohort analysis. RESULTS: Global Burden of Disease analyses (1990-2021) show 2021 ADRD incidence of 119.76/100,000, with 450.98 DALYs and 309.03 YLL/100,000. Post-2019 COVID-19 onset, all SDI regions except high-SDI exhibited significant ADRD incidence increases (P < 0.05). Women ≥55 years had the highest burden, with behavioral risks contributing most to DALYs (2021). China showed the steepest ADRD incidence rise (1990-2021), accelerating post-COVID-19, contrasting declines in Denmark and Australia. COVID-19 ASIR (2020) and ADRD ASPR (2020) had a standardized path coefficient of 0.237 (P < 0.05); COVID-19 ASIR (2020) and ADRD ASPR (2021) covariance reached 0.275 (P < 0.05). Projections suggest declining ASIR for ages 40-79 but rising ASIR for ≥80 by 2050. CONCLUSION: To effectively mitigate the ongoing rise in ADRD, particularly among older women and middle-high SDI populations, targeted prevention and control strategies must be developed, with careful consideration of socioeconomic factors and the long-term impacts of COVID-19.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2026-11-18
DOI
https://doi.org/10.1371/journal.pone.0359947
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The global burden of Alzheimer’s disease and related dementias: New public health intervention targets driven by the long-term impact of COVID-19 and sex and age differences

Si Chen, Zhengyang Xu, Manchun Cai, Yan Song et al.
7 links
PLoS ONE
Dementia and Cognitive Impairment Research
article

The global burden of Alzheimer’s disease and related dementias: New public health intervention targets driven by the long-term impact of COVID-19 and sex and age differences

Si Chen, Zhengyang Xu, Manchun Cai, Yan Song, YuRui Bai, Wentao Zheng
article en

Abstract

INTRODUCTION: This study focuses on the impact and future trends of COVID-19 on the burden of Alzheimer's disease and related dementias (ADRD), analyzing multidimensional differences in the burden of disease for ADRD in 204 countries between 1990 and 2021. METHODS: Using Global Burden of Disease (GBD) data (1990-2021), we analyzed Alzheimer's disease and related dementias (ADRD) prevalence and burden across 204 countries, stratified by sex and age. Joinpoint regression identified temporal inflection points in incidence, mortality, disability-adjusted life years (DALYs), and years of life lost (YLL), while age-standardized rates and estimated annual percentage changes assessed global burden trends. We further evaluated ADRD-associated risk factors, quantified COVID-19's impact through excess burden attribution models, and projected incidence trajectories to 2050 via Bayesian Age-Period-Cohort analysis. RESULTS: Global Burden of Disease analyses (1990-2021) show 2021 ADRD incidence of 119.76/100,000, with 450.98 DALYs and 309.03 YLL/100,000. Post-2019 COVID-19 onset, all SDI regions except high-SDI exhibited significant ADRD incidence increases (P < 0.05). Women ≥55 years had the highest burden, with behavioral risks contributing most to DALYs (2021). China showed the steepest ADRD incidence rise (1990-2021), accelerating post-COVID-19, contrasting declines in Denmark and Australia. COVID-19 ASIR (2020) and ADRD ASPR (2020) had a standardized path coefficient of 0.237 (P < 0.05); COVID-19 ASIR (2020) and ADRD ASPR (2021) covariance reached 0.275 (P < 0.05). Projections suggest declining ASIR for ages 40-79 but rising ASIR for ≥80 by 2050. CONCLUSION: To effectively mitigate the ongoing rise in ADRD, particularly among older women and middle-high SDI populations, targeted prevention and control strategies must be developed, with careful consideration of socioeconomic factors and the long-term impacts of COVID-19.

PLoS ONEVol. 21(11)
Beihua University (CN), Erasmus MC (NL), Qujing Normal University (CN)
People's Government of Jilin Province, Education Department of Jilin Province, Department of Science and Technology of Jilin Province, Beihua University
Good health and well-being
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon